Drugs / ATL-104
last change Dec 2005 re-read 3 minutes ago

ATL-104

Developed for
mucositis
Investigated by
Alizyme

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00163280 Jul 2004 → Dec 2005 mucositis Alizyme Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ATL-104 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00163280 ↗